Robert E. Landry - Oct 31, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Finance CFO
Signature
/s/**Robert E. Landry
Stock symbol
REGN
Transactions as of
Oct 31, 2022
Transactions value $
-$741,929
Form type
4
Date filed
11/2/2022, 04:04 PM
Previous filing
Oct 18, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $764K +2K +6.96% $381.92 30.7K Oct 31, 2022 Direct F1
transaction REGN Common Stock Tax liability -$1.14M -1.52K -4.94% $751.24 29.2K Oct 31, 2022 Direct F1
transaction REGN Common Stock Sale -$750 -1 0% $750.00 29.2K Nov 1, 2022 Direct F1
transaction REGN Common Stock Sale -$30.1K -40 -0.14% $753.23 29.2K Nov 1, 2022 Direct F1
transaction REGN Common Stock Sale -$60.4K -80 -0.27% $754.39 29.1K Nov 1, 2022 Direct F1, F2
transaction REGN Common Stock Sale -$61.2K -81 -0.28% $755.46 29K Nov 1, 2022 Direct F1, F3
transaction REGN Common Stock Sale -$31.8K -42 -0.14% $758.20 29K Nov 1, 2022 Direct F1, F4
transaction REGN Common Stock Sale -$53.2K -70 -0.24% $759.39 28.9K Nov 1, 2022 Direct F1, F5
transaction REGN Common Stock Sale -$9.89K -13 -0.04% $760.90 28.9K Nov 1, 2022 Direct F1, F6
transaction REGN Common Stock Sale -$90.6K -119 -0.41% $761.36 28.8K Nov 1, 2022 Direct F1, F7
transaction REGN Common Stock Sale -$13K -17 -0.06% $762.92 28.8K Nov 1, 2022 Direct F1
transaction REGN Common Stock Sale -$14.5K -19 -0.07% $763.10 28.7K Nov 1, 2022 Direct F1
holding REGN Common Stock 250 Oct 31, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -17.7% $0.00 9.3K Oct 31, 2022 Common Stock 2K $381.92 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 80 shares of Company stock on November 1, 2022 at prices ranging from $754.20 to $754.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 81 shares of Company stock on November 1, 2022 at prices ranging from $755.03 to $755.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 42 shares of Company stock on November 1, 2022 at prices ranging from $758.15 to $758.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 70 shares of Company stock on November 1, 2022 at prices ranging from $759.23 to $759.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 13 shares of Company stock on November 1, 2022 at prices ranging from $760.81 to $760.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 119 shares of Company stock on November 1, 2022 at prices ranging from $761.19 to $761.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F8 The stock option award vests in four equal annual installments, commencing one year after the date of grant.